PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
The Korean Journal of Medicine10.3904/kjm.2018.93.3.2662018933266-270Diagnosis and Treatment of Non-Squamous Lung Cancer Based on Molecular Tumor TestingSung Yong Leehttp://ekjm.org/upload/kjm-2018-93-3-266.pdf, http://ekjm.org/journal/view.php?doi=10.3904/kjm.2018.93.3.266, http://ekjm.org/upload/kjm-2018-93-3-266.pdf
Lung Cancer10.1016/s0169-5002(86)80047-2198623211Monoclonal antibodies to human squamous cell carcinoma of the lung and their application to tumor diagnosishttp://api.elsevier.com/content/article/PII:S0169500286800472?httpAccept=text/xml, http://api.elsevier.com/content/article/PII:S0169500286800472?httpAccept=text/plain
Lung Cancer: Targets and Therapy10.2147/lctt.s73268201513Pemetrexed in maintenance treatment of advanced non-squamous non-small-cell lung cancerSeigo Minami, Takashi Kijimahttps://www.dovepress.com/getfile.php?fileID=23477
Lung Cancer10.1016/0169-5002(96)87794-41996142-3390Molecular genetic tumor markers in the early diagnosis and screening of non-small-cell lung cancerhttp://api.elsevier.com/content/article/PII:0169500296877944?httpAccept=text/xml, http://api.elsevier.com/content/article/PII:0169500296877944?httpAccept=text/plain
Lung Cancer10.1016/j.lungcan.2010.09.0072010702230Corrigendum to “Effectiveness of bevacizumab- and pemetrexed-cisplatin treatment for patients with advanced non-squamous non-small cell lung cancer” [Lung Cancer 69S1 (2010) S4–S10]http://api.elsevier.com/content/article/PII:S0169500210004381?httpAccept=text/xml, http://api.elsevier.com/content/article/PII:S0169500210004381?httpAccept=text/plain
Lung Cancer10.1016/0169-5002(94)90734-x1994105-6391-392Results of early diagnosis and surgical treatment for bronchogenic squamous cell carcinomahttp://api.elsevier.com/content/article/PII:016950029490734X?httpAccept=text/xml, http://api.elsevier.com/content/article/PII:016950029490734X?httpAccept=text/plain
Lung Cancer10.1016/0169-5002(94)92275-61994115-6443Recent advances in diagnosis and treatment of small cell and non-small cell lung cancerhttp://api.elsevier.com/content/article/PII:0169500294922756?httpAccept=text/xml, http://api.elsevier.com/content/article/PII:0169500294922756?httpAccept=text/plain
Lung Cancer10.1016/j.lungcan.2013.09.0182013823469-476Treatment patterns and outcomes in patients with non-squamous advanced non-small cell lung cancer receiving second-line treatment in a community-based oncology networkI.W. Pan, R. Mallick, R. Dhanda, E. Nadlerhttp://api.elsevier.com/content/article/PII:S0169500213004443?httpAccept=text/xml, http://api.elsevier.com/content/article/PII:S0169500213004443?httpAccept=text/plain
Lung Cancer10.1016/j.lungcan.2018.05.006201812176-81Association of molecular status and metastatic organs at diagnosis in patients with stage IV non-squamous non-small cell lung cancerC.C.H.J. Kuijpers, L.E.L. Hendriks, J.L. Derks, A-M.C. Dingemans, A.S.R. van Lindert, M.M. van den Heuvel, R.A. Damhuis, S.M. Willemshttp://api.elsevier.com/content/article/PII:S0169500218303702?httpAccept=text/xml, http://api.elsevier.com/content/article/PII:S0169500218303702?httpAccept=text/plain
Respirology10.1111/j.1440-1843.2012.02261.x2013182233-237Clinical testing for molecular targets for personalized treatment in lung cancerDAVID C.L. LAMhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1440-1843.2012.02261.x